And the europeans need to take necessary actions. The United States has basically in my view for a shot itself in the foot by withdrawing from this agreement. Nejra netflix slumps. A drop in u. S. Customers and slowing growth overseas. Shares plummet in extended trade. In europe, watching for results from s. A. P. Welcome to daybreak europe, just on 6 00 a. M. In london. Numbers from novartis are coming through. Second quarter core operating profit, at 3. 65 billion. The Second Quarter core eps, 1. 34. Second quarter net sales, 11. 76 billion. 2019 guidance has been raised for the new focused medicines, and they named a president of pharmaceuticals. They see d sales up mid to high sigel digits. To give you more detail, the Second Quarter sales, 858 million, the estimate of 868 million. A little miss on Second Quarter sales. Were waiting for a few more numbers to come through. 2019 sales guides race for both for both raised units for novartis. Manus, what do we see in the broader market
Britain wants from a future trade pact. A warm welcome. This is bloomberg daybreak europe. I am anna edwards. Novartis. Will talk to some news breaking. In. Rtis numbers coming core earnings per share for the beat, quarter is a 1. 29. 3. 3 8 billion thirdquarter operating profit. This would be the first quarterly profit increase in three years. Helping them. The core earnings per share is a nice beat, thirdquarter profit 3. 3 billion. Novartis sees significant in the 2017 outlook is reconfirmed. Anna some hoping there might be a decision on that. Basf, how about strong is the chemicals story for this company . Thirdquarter revenue ahead of vestments. Adjusted eve also in line. Of the portfolio is in that area. Are they going to fix the guidance . Germany on at of 1. 5 billion Share Buyback program plan to start in the fourth quarter. I wontumber at give you that. That looks to be inconsistent. Is 491 income number million euros. Numberction on the sales , 3. 5 billion euros. Both those